Patient order management (POM) is a mission-critical task for perioperative workflow. Interface complexity within different EHR systems result in poor usability, increasing documentation burden. POM interfaces were compared across two systems prior to (Cerner SurgiNet) and subsequent to an EHR conversion (Epic). Here we employ a navigational complexity framework useful for examining differences in EHR interface systems. The methodological approach includes 1) expert-based methods-specifically, functional analysis, keystroke level model (KLM) and cognitive walkthrough, and 2) quantitative analysis of observed interactive user behaviors. We found differences in relation to navigational complexity with the SurgiNet interface displaying a higher number of unused POM functions, with 12 in total whereas Epic displayed 7 total functions. As reflected in all measures, Epic facilitated a more streamlined task-focused user experience. The approach enabled us to scrutinize the impact of different EHR interfaces on task performance and usability barriers subsequent to system implementation.With vast amounts ofpatients' medical information, electronic health records (EHRs) are becoming one of the most important data sources in biomedical and health care research. Effectively integrating data from multiple clinical sites can help provide more generalized real-world evidence that is clinically meaningful. To analyze the clinical data from multiple sites, distributed algorithms are developed to protect patient privacy without sharing individual-level medical information. In this paper, we applied the One-shot Distributed Algorithm for Cox proportional hazard model (ODAC) to the longitudinal data from the OneFlorida Clinical Research Consortium to demonstrate the feasibility of implementing the distributed algorithms in large research networks. We studied the associations between the clinical risk factors and Alzheimer's disease and related dementia (ADRD) onsets to advance clinical research on our understanding of the complex risk factors of ADRD and ultimately improve the care of ADRD patients.Adverse drug events (ADE) are prevalent and costly. Clinical trials are constrained in their ability to identify potential ADEs, motivating the development of spontaneous reporting systems for post-market surveillance. Statistical methods provide a convenient way to detect signals from these reports but have limitations in leveraging relationships between drugs and ADEs given their discrete count-based nature. A previously proposed method, aer2vec, generates distributed vector representations of ADE report entities that capture patterns of similarity but cannot utilize lexical knowledge. https://www.selleckchem.com/products/az-3146.html We address this limitation by retrofitting aer2vec drug embeddings to knowledge from RxNorm and developing a novel retrofitting variant using vector rescaling to preserve magnitude. When evaluated in the context of a pharmacovigilance signal detection task, aer2vec with retrofitting consistently outperforms disproportionality metrics when trained on minimally preprocessed data. Retrofitting with rescaling results in further improvements in the larger and more challenging of two pharmacovigilance reference sets used for evaluation.Our previous research shows that structured cancer DX description data accuracy varied across electronic health record (EHR) segments (e.g. encounter DX, problem list, etc.). We provide initial evidence corroborating these findings in EHRs from patients with diabetes. We hypothesized that the odds of recording an "uncontrolled diabetes" DX increased after a hemoglobin A1c result above 9% and that this rate would vary across EHR segments. Our statistical models revealed that each DX indicating uncontrolled diabetes was 2.6% more likely to occur post-A1c>9% overall (adj-p=.0005) and 3.9% after controlling for EHR segment (adj-p less then .0001). However, odds ratios varied across segments (1.021 less then OR less then 1.224, .0001 less then adj-p less then .087). The number of providers (adj-p less then .0001) and departments (adjp less then .0001) also impacted the number of DX reporting uncontrolled diabetes. Segment heterogeneity must be accounted for when analyzing clinical data. Understanding this phenomenon will support accuracy-driven EHR data extraction to foster reliable secondary analyses of EHR data.Many adverse drug reactions (ADRs) are caused by drug-drug interactions (DDIs), meaning they arise from concurrent use of multiple medications. Detecting DDIs using observational data has at least three major challenges (1) The number of potential DDIs is astronomical; (2) Associations between drugs and ADRs may not be causal due to observed or unobserved confounding; and (3) Frequently co-prescribed drug pairs that each independently cause an ADR do not necessarily causally interact, where causal interaction means that at least some patients would only experience the ADR if they take both drugs. We address (1) through data mining algorithms pre-filtering potential interactions, and (2) and (3) by fitting causal interaction models adjusting for observed confounders and conducting sensitivity analyses for unobserved confounding. We rank candidate DDIs robust to unobserved confounding more likely to be real. Our rigorous approach produces far fewer false positives than past applications that ignored (2) and (3).While the utility of computerized clinical decision support (CCDS) for multiple select clinical domains has been clearly demonstrated, much less is known about the full breadth of domains to which CCDS approaches could be productively applied. To explore the applicability of CCDS to general medical knowledge, we sampled a total of 500 primary research articles from 4 high-impact medical journals. Employing rule-based templates, we created high-level CCDS rules for 72% (361/500) of primary medical research articles. We subsequently identified data sources needed to implement those rules. Ourfindings suggest that CCDS approaches, perhaps in the form of non-interruptive infobuttons, could be much more broadly applied. In addition, our analytic methods appear to provide a means of prioritizing and quantitating the relative utility of available data sources for purposes of CCDS.